Navigation Links
Trial Shows Heart Attack Education Makes Little Difference

But new study design might change response times, researcher says

WEDNESDAY, Oct. 7 (HealthDay News) -- A study to tell whether educating heart patients about the symptoms of heart attack would make them respond faster when one happens has produced negative results, but the researchers say a few changes in trial design might make a second look at the issue worthwhile.

The research included 3,522 people with known heart disease in six cities in the United States, Australia and New Zealand. Half were given lessons on the symptoms of a heart attack and what to do when they occurred -- essentially, get to a hospital quickly -- with a follow-up call a month later to be sure the lessons had been learned. The other half received standard medical care. Both groups were called every six months to check whether they had sought emergency heart care.

Among the 3,087 people who were followed for two years, 305 in the education group sought emergency care, compared to 260 in the no-education group. The average time from symptoms to hospital admission was virtually the same for the two groups -- 2.20 hours with education, 2.25 hours without education, the researchers found.

But there should have been a third group in the study, said Barbara J. Riegel, a professor of nursing at the University of Pennsylvania and a member of the consortium of nurses reporting the trial in the Oct. 6 online edition of Circulation.

That would be a group that received neither education nor follow-up phone calls, she said.

The follow-up phone calls made to people in the no-education group might have made them more aware of the need to seek emergency care, Riegel explained.

"The response times were actually pretty low," Riegel said of both groups. "The fact that we called frequently to collect data might have affected their responses."

And so another trial with a third group that is left alone entirely is needed, Riegel said, and some changes might be made in the education program. "We'd like to do a study with a more powerful intervention," she said. "The one booster call a month later might not be strong enough to alter the response time."

Plans for such a study already are being made, with hopes for government funding. And meanwhile, Riegel said, the trial was not a total loss. "We've learned a ton from this one," she said.

The heart attack symptom that everyone knows is discomfort and/or pain in the chest that lasts for a few minutes or recurs. Other symptoms can include discomfort in the upper part of the body, perhaps affecting the arms, the back or the jaw; shortness of breath, with or without chest pain; a cold sweat, nausea or lightheadedness. A 911 call for emergency medical service or a quick trip to a hospital emergency room is recommended when those symptoms occur, with artery-clearing treatment most effective when started within 90 minutes of onset.

There were glimmers of hope in the results. Response times in the education group were shorter in the first six months after the education session, and people in the education group were more likely to take aspirin, which helps prevent artery-blocking blood clots, when they felt chest pain or had other heart attack symptoms.

But the trial's disappointing results might have been influenced by another possible mistake, which was downplaying the dangers of a delayed response during the education phase of the trial, said study leader Kathleen Dracup, dean of the school of nursing at the University of California, San Francisco.

"We assured patients about the interventions that would reverse the [heart attack] process," Dracup said. "We emphasized the positives about seeking help early, and didn't focus on what happens when you don't seek help early. We wanted to reassure patients that the health-care system would take care of them, when in reality the dangers can always be great."

A realistic description of what might happen if response to a heart attack is delayed will be part of any future trial, Dracup added.

More information

The symptoms of a heart attack, and what to do when it occurs, are described by the American Heart Association.

SOURCES: Barbara J. Riegel, R.N., DNSc, professor, nursing, University of Pennsylvania, Philadelphia; Kathleen Dracup, R.N., DNSc, dean, school of nursing, University of California, San Francisco; Oct. 6, 2009, Circulation, online

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Vital Therapies Initiates Liver Stabilization Trial
2. Cardiac stem cell trial seeks to treat some heart attack patients
3. UCSF Announces Expanded Website
4. 2009 National Ergonomics Conference Coming To Las Vegas In November; Features Strategies For Dealing With A Slow Economy & Aging Workforce In Office, Industrial, Healthcare & Uncontrolled Work Environments
5. Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients
6. Innovation and Global Clinical Trial Participation are the Focus of CenterWatch's Latest Special Report on China's Drug Development Industry
7. Women With Atrial Fibrillation Face Rougher Road Than Men
8. Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
9. Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcanos VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
10. Video: New Clinical Trial Results Show Germ-Killing Action of LISTERINE(R) Antiseptic Kills Germs in the Mouth Before They Travel to the Bloodstream
11. SPIRIT IV trial shows everolimus stent sets new standard for event-free survival
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone ... member, close friend, or animal pass away, death lives among us. It is your ... Coming from a family of 11 children, author T Sky understands that she may ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announce the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming ... value-based care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel ...
(Date:11/30/2015)... IL (PRWEB) , ... November 30, 2015 , ... The ... an emerging pharmaceutical company. Because it is so important to this key industry segment, ... Factors in your IND Filing” on December 4th at 11am EST. , Federal law ...
(Date:11/30/2015)... ... November 30, 2015 , ... Insightra Medical, Inc. ... Surgical Mesh technology for soft tissue repair in the US via Insightra’s national ... resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... & Laser Center is one of a select few plastic surgeons in the ... non-surgical fat removal. , SculpSure™ is the world’s first heat-induced laser treatment for ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... -- Booth #4303 – The Imaging Components business of Varian ... array of products in a new booth (#4303) at the ... America in Chicago this ... components "At the Heart of Imaging." Products will include a ... Claymount brand, and computer-aided diagnostic software from MeVis as well ...
(Date:11/30/2015)... -- Hanger, Inc. (NYSE: HGR ) (the "Company") today ... its previously announced consent solicitation (as amended and restated, ... amount 7⅛% Senior Notes due 2018 (the "Notes") to ... pursuant to the Consent Solicitation, (ii) the proposed increased ... date of the Consent Solicitation.    ...
(Date:11/30/2015)... , Nov. 30, 2015   VolitionRx Limited (NYSE ... diagnostic tests for a broad range of cancer types and ... LD Micro Conference, which will be held December 1 - 3 ... from VolitionRx will be David Kratochvil , Chief Financial ... of Investor Relations. ® blood-based tests for ...
Breaking Medicine Technology: